![]() PNVL3 3 weeks ago Paid | Quarterly | R$0.09 Per Share |
![]() PNVL3 3 weeks ago | Other | R$0.09 Per Share |
![]() PNVL3 3 months ago Announced | Other | R$0.09 Per Share |
![]() PNVL3 7 months ago Paid | Other | R$0.1 Per Share |
![]() PNVL3 9 months ago Paid | Other | R$0.09 Per Share |
12 Aug 2025 (In 2 weeks) Date | | - Cons. EPS | - EPS |
12 Aug 2025 (In 2 weeks) Date | | - Cons. EPS | - EPS |
8 Nov 2023 Date | | - Cons. EPS | - EPS |
![]() PNVL3 3 weeks ago Paid | Quarterly | R$0.09 Per Share |
![]() PNVL3 3 weeks ago | Other | R$0.09 Per Share |
![]() PNVL3 3 months ago Announced | Other | R$0.09 Per Share |
![]() PNVL3 7 months ago Paid | Other | R$0.1 Per Share |
![]() PNVL3 9 months ago Paid | Other | R$0.09 Per Share |
12 Aug 2025 (In 2 weeks) Date | | - Cons. EPS | - EPS |
12 Aug 2025 (In 2 weeks) Date | | - Cons. EPS | - EPS |
8 Nov 2023 Date | | - Cons. EPS | - EPS |
Drug Manufacturers - General Industry | Healthcare Sector | Mr. Julio Ricardo Mottin Neto Neto CEO | B3 Exchange | BRPNVLACNOR9 ISIN |
BR Country | 10,284 Employees | 4 Jul 2025 Last Dividend | 23 Mar 2020 Last Split | - IPO Date |